ARCHIVES

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

This article is from The Cancer Letter archive.

Vol. 14 No. 41 | October 21, 1988

Download PDF Visit The Full Archive

Related Articles

DCT Advisors Approve Grants Program For Trials Of BRMs

March 10, 1995

ORI Withdraws Requirement For Research Ethics Courses.

February 23, 2001

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

December 27, 2013

Surgeon General’s report adds to list of smoking-related cancers, other diseases.

June 4, 2004

Letter: Medicare Policy May Delay Access to Cancer Drugs

June 13, 2003

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

July 11, 2014